Stockreport

Ultragenyx says three patients in phase 1/2 gene therapy study had positive results [MarketWatch]

Ultragenyx Pharmaceutical Inc.  (RARE) 
Last ultragenyx pharmaceutical inc. earnings: 2/13 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ultragenyx.com/investor-relations
PDF Ultragenyx says three patients in phase 1/2 gene therapy study had positive results Ultragenyx Pharmaceutical Inc. RARE, -0.71% shares rose 2.5% in premarket trade We [Read more]